Maternal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) alters indolamine levels and turnover in adult male and female rat brain regions

Brain Research Bulletin

Volumn 43, Issue 2, 1997, Pages 173-178

  Molina Holgado, Francisco ^a,b   Alvarez, Francisco J ^a   Gonzalez, Isabel ^a,c   Antonio, Maria T ^a   Leret, Maria L ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

9 Tetrahydrocannabinol; 5 HIAA; 5 HT; 5 HTP; HPLC ED; Perinatal; Turnover

Indexed keywords

INDOLEAMINE; TETRAHYDROCANNABINOL;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CANNABIS ADDICTION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC NERVE;

ANIMALS; BRAIN; FEMALE; INDOLES; MALE; MATERNAL EXPOSURE; RATS; RATS, WISTAR; SEX FACTORS; TETRAHYDROCANNABINOL;

EID: 0030871619     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00434-0     Document Type: Article

References (48)

1. Azmitia E. C., Dolan K., Whitaker-Azmitia P. M. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res. 516:1990;354-356.
2. Baraban J. M., Aghajanian G. K. Noradrenergic innervation of serotoninergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography. Brain Res. 204:1981;1-11.
3. 9 -tetrahydrocannabinol on brain amine concentration and turnover in whole rat brain and in various regions of the brain. J. Pharm. Pharmacol. 27:1975;713-715.
4. Crespi F., Garratt J. C., Sleight A. J., Marsden C. A. In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience. 35:1990;139-144.
5. Chubacov A. R., Gromova G. V., Konovalov G. V., Sarkisova E. F., Chumasov E. I. The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res. 369:1986;285-297.
6. Dalterio S. L., Steger R. W., Bartke A. Maternal or parental exposure to cannabinoids affects central neurotransmitter levels and reproductive function in male offsprings. The cannabinoids chemical and therapeutic aspects. 1981;411-425 Academic Press, New York.
7. Dewane W. A., Dysarz F. A., Jhonson M. R., Melvin L. S., Howlett A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
8. Dewane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandlebaun A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
9. 3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum and midbrain raphe nuclei region. Synapse. 9:1991;14-26.
10. Felder C. C., Veluz J. S., Williams H. L., Briley E. M., Matsuda L. A. Cannabinoid agonist stimulated both receptor and nonreceptor signal transduction pathways in cells transfected with and-expressing cannabinoid receptor clones. J. Pharmacol. Exp. Ther. 42:1992;838-845.
11. Fernandez Ruiz J. J., et al. Maternal cannabinoid exposure and brain development: Changes in the ontogeny of dopaminergic neurons. Murphy L., Bartke A. Marijuana/cannabinoids (neurobiology and neurophysiology). 1992;CRC Press, Boca Raton, FL.
12. 2 receptor mediate regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J. Neurochem. 61:1993;772-775.
13. Ferre S., Cortes R., Artigas F. Dopaminergic regulation of the serotoninergic raphe-striatal pathway: Microdialysis studies in freely moving rats. J. Neurosci. 14:1994;4839-4846.
14. Gaony Y., Mechoulam R. Isolation, structure and partial synthesis on an active constituent of hashish. J. Am. Chem. Soc. 86:1964;1646-1654.
15. Gerard C. M., Mollereau C., Vassart G., Partmemtier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. J. Biochem. 279:1991;129-134.
16. Herkenham M., Lynn A. B., Johnson M. R., de Costa B. R., Rice K. C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
17. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa B. R., Rice K. C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA. 87:1990;1932-1936.
18. 14C-THC to the mother. Eur. J. Pharmacol. 22:1973;221-223.
19. 3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Dev. Brain Res. 78:1978;142-146.
20. Le Fevre R. A., Aisenthal L., Rothwen N. J. Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res. 555:1991;245-250.
21. Lidov H. G. W., Molliver M. E. An inmunohistochemical study of serotonin neuron development in the rat: Ascending pathways and terminal fields. Brain Res. Bull. 8:1981;389-430.
22. Lowry D. H., Rosenbrough H. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;256-276.
23. 9 -Tetrahydrocannabinol a novel treatment for experimental autoinmune encephalomyelitis. J. Neuroinmunol. 23:1989;73-81.
24. 3H-Delta-9-Tetrahydrocannabinol distribution in pregnant dogs and their foetuses. Res. Chem. Pathol. Pharmacol. 17:1977;457-470.
25. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 456:1990;561-564.
26. Mirmiran M., Swaab D. F. Influence of drugs on brain neurotransmitter and behavioral states during development. Dev. Pharmacol. Ther. 10:1987;377.
27. Molina-Holgado E., Dewar K. M., Descarries L., Reader T. A. Altered dopamine and serotonin metabolism in the dopamine denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270:1994;713-720.
28. 9 -tetrahydrocannabinol on short-term memory in the rat. Physiol. Behav. 57:1994;177-179.
29. 9 -Tetrahydrocannabinol treatment. J. Neurochem. Res. 18:1993;1183-1191.
30. 9 -Tetrahydrocannabinol on copulatory behavior and neuroendocrine responses of male rats to female conspecifics. Pharmacol. Biochem. Behav. 48:1994;1011-1017.
31. Navarro M., guez de Fonseca F., Hernandez M. L., Ramos J. A., Fernandez Ruiz J. J. Motor behavior and nigrostriatal dopaminergic activity in adults rats exposed to cannabinoids. Pharmacol. Biochem. Behav. 47:1994;47-58.
32. 9 -Tetrahydrocannabinol. An ontogenic study in Wistar rats. Psychopharmacology (Berlin). 116:1994;414-422.
33. Pellegrino L. J., Pellegrino A. S., Cushman A. J. A stereotaxic atlas of the rat brain. 2nd ed. 1981;Plenum Press, New York.
34. Pertwee R. G., Greentree S. G., Swift P. A. Drugs stimulate or facilitate central GABAergic transmission interact synergistically with Δ -9-Tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology. 27:1988;1256-1270.
35. Reader, T. A. Neurotoxins that affect central indolamine neurons. In: Boulton, A. B.; Baker, G. B.; Juorio, A., eds. Neuromethods, vol. 12: Drugs as tools in neurotransmitter research. New Jersey; 1989:49-51.
36. Rodriguez de Fonseca F., Cebeira M., Fernandez Ruiz J. J., Navarro M., Ramos J. A. Effects of pre and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43:1991;713-723.
37. 9 -Tetrahydrocannabinol administration affects anterior pituitary, corticoadrenal and adrenomedullary functions in male rats. Neuroendocrinology (Life Sci. Adv.). 11:1992;147-156.
38. 9 -Tetrahydro-cannabinol on dopaminergic activity in several rat brain areas. Pharmacol. Biochem. Behav. 42:1992;269-275.
39. 9 -Tetrahydrocannabinol treatment. Pharmacol. Biochem. Behav. 47:1994;33-40.
40. 8 -Tetrahydrocannabinol-dimethylheptyl-induced catalepsy in male rats. Neuroreport. 5:1994;761-765.
41. 9 -Tetrahydrocannabinol administered by inhalation or orally to rats. Brande M. C., Szara S. The pharmacology of marihuana. 1976;571-584 Raven Press, New York.
42. Scoepp D. D., Azzro A. J. Specifity of endogenous substrates for types A and B monoamine oxidase in rat striatum. J. Neurochem. 36:1981;2025-2031.
43. 9 -Tetrahydrocannabinol on serotonin metabolism in the rat brain. Life Sci. 10:1971;425-436.
44. Strosznajder J., Samochocki M., Duran M. Serotonin, a potent modulator of arachidonic acid turnover, interaction with glutamatergic receptor in brain cortex. Neurochem. Int. 25:1994;193-199.
45. 9 -THC) on the turnover rate of brain serotonin of the rat. Clin. Exp. Pharmacol. Physiol. 6: 1979;27-334.
46. 9 -Tetrahydrocannabinol on brain and plasma catecholamine levels as measured by HPLC. Brain Res. Bull. 14:1985;85-90.
47. Walters D. E., Carr L. A. Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol. Biochem. Behav. 29:1988;213-216.
48. Whitaker-Azmitia P. M., Azmitia E. C. Stimulation of astroglial serotonin receptors produces culture media wich regulates growth of serotoninergic neurons. Brain Res. 497:1989;80-85.